Precursor B-cell Lymphoblastic Leukemia Lymphoma
📧 Sign up to get email alerts when something new happens for Precursor B-cell Lymphoblastic Leukemia Lymphoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-02-05EMA Authorised: Dasatinib Accord Healthcare (Dasatinib monohydrate) — Accord Healthcare S.L.U.
EMA authorised Accord Healthcare's dasatinib monohydrate product (Dasatinib Accord Healthcare) for precursor B-cell lymphoblastic leukemia/l…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial [EARLY_Phase 1]
This update describes an early-phase dose-escalation trial evaluating CART123 T cells in relapsed or refractory CD123+ hematologic malignanc…
-
EMA approval · 2025-08-19EMA Authorised: Aucatzyl (obecabtagene autoleucel) — Autolus GmbH
EMA authorised Aucatzyl (obecabtagene autoleucel) from Autolus GmbH for precursor B-cell lymphoblastic leukemia/lymphoma, under conditional …
-
EMA withdrawal · 2022-07-05EMA Withdrawn: Imatinib Actavis (imatinib) — Actavis Group PTC ehf
EMA withdrawn Imatinib Actavis (imatinib) from the market, with indications including chronic myeloid leukemia, precursor B-ALL/lymphoma, my…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Safety Study of SGN-CD19A for B-Cell Lymphoma [Phase 1]
Phase 1 safety study of SGN-CD19A in various B-cell lymphomas has completed; the update summarizes safety results across multiple indication…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating repeat-dose lenalidomide plus dexamethasone in precursor B-cell lymphoblastic leukemia/lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Safety Study of SGN-CD19A for Leukemia and Lymphoma [Phase 1]
Phase 1 safety study of SGN-CD19A in patients with Burkitt lymphoma and precursor B-cell lymphoblastic leukemia/lymphoma has completed.
-
CLINICAL_TRIALS withdrawal · 2017-04-10Clinical Trial Update: A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
A clinical trial evaluating JCAR015 in adults with B-cell acute lymphoblastic leukemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603) [Phase 2]
Phase 2 clinical trial update on bone marrow transplantation from partially matched donors with nonmyeloablative conditioning for various bl…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604) [Phase 2]
Phase 2 clinical trial evaluating safety and effectiveness of an umbilical cord blood stem cell transplant for various hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
This clinical trial update notes the termination of a Phase 1/2 study evaluating nilotinib in combination with chemotherapy for Philadelphia…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Coproporphyrine Isomers and Methotrexate Elimination
This completed clinical trial update investigates coproporphyrin isomer profiles and methotrexate elimination in patients with Central Nervo…